BioSpace News Archive

ONE Cannabis, a Denver-Based Cannabis Franchisor, Exhibits at the Industry-Leading Event to Break Down Myths and Teach Franchising Pros about the Legal Cannabis Market

The National Color Coalition announced the winners of the Color Me with Love Video Contest.

Advicenne, a pharmaceutical company specializing in the development of adult and pediatric therapeutic products for the treatment of orphan renal and neurological diseases, announces its financial results for the full year ended December 31, 2018.

The Quality-Driven Delivery Platform Promises to Provide Exclusive Cannabis Products to Your Door in under 45 minutes

Multiple Sclerosis Association of America focuses 2019 awareness campaign on family, relationships and care partner needs

Non-profit convenes board of directors, launches executive director search, begins work of establishing strategic priorities

Enzyvant, a biopharmaceutical company focused on developing and commercializing transformative therapies for patients with rare diseases, today announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease and Fast Track designations for RVT-801, an investigational enzyme replacement therapy.

Gout has plagued human for hundreds of years but new evidence shows how to understand it better and treat it more effectively

Aura Biosciences announced that interim clinical data from its Phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011, the Company’s lead product candidate for the primary treatment of primary choroidal melanoma, will be highlighted in an oral presentation at the International Society of Ocular Oncology 2019 Annual Meeting being held March 22-26, 2019, in Los Angeles.

AgeX Therapeutics, Inc., a biotechnology company focused on innovative therapeutics for human aging, announced that the company will present in multiple sessions at Undoing Aging 2019, March 28-30 in Berlin, Germany.